Sign in

    Ron Kamdem

    Research Analyst at Morgan Stanley

    Ron Kamdem serves as Managing Director and Head of U.S. Real Estate Investment Trusts (REITs) and Commercial Real Estate Research at Morgan Stanley, specializing in REITs and U.S. real estate markets. He covers a broad portfolio of companies, including names such as Prologis and American Healthcare REIT, and has delivered a 56% success rate with an average return per rating of 4.4% according to TipRanks. Beginning his analyst career in 2007, Kamdem joined Morgan Stanley and progressed to lead the REIT and commercial real estate research team, frequently appearing in financial media for sector insight. He maintains active professional licenses and registrations, including FINRA certifications, and is recognized for thought leadership on the transformative impact of AI and market dynamics within commercial real estate.

    Ron Kamdem's questions to SIMON PROPERTY GROUP INC /DE/ (SPG) leadership

    Ron Kamdem's questions to SIMON PROPERTY GROUP INC /DE/ (SPG) leadership • Q3 2024

    Question

    Ronald Kamdem noted the strong domestic NOI growth of nearly 5% and asked for updated commentary on achieving a 3% growth target for the next year, as well as any performance differentiation between traditional malls and outlets.

    Answer

    David Simon, Chairman, CEO, and President, acknowledged the strong performance and stated that momentum is expected to continue. However, he declined to provide specific 2025 NOI growth guidance, indicating that the company is currently in its budgeting process and will share its formal outlook during the year-end earnings call in February. He confirmed that all platforms are generally moving in a positive direction.

    Ask Fintool Equity Research AI